Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.

Mannon PJ.

Expert Opin Biol Ther. 2011 Sep;11(9):1249-56. doi: 10.1517/14712598.2011.602967. Epub 2011 Jul 25. Review.

PMID:
21787241
2.

Remestemcel-L for the treatment of graft versus host disease.

Locatelli F, Algeri M, Trevisan V, Bertaina A.

Expert Rev Clin Immunol. 2017 Jan;13(1):43-56. Epub 2016 Jul 29. Review.

PMID:
27399600
3.

Remestemcel-L for acute graft-versus-host disease therapy.

Chen GL, Paplham P, McCarthy PL.

Expert Opin Biol Ther. 2014 Feb;14(2):261-9. doi: 10.1517/14712598.2014.873027. Epub 2013 Dec 19. Review.

PMID:
24350681
4.

Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells.

Voswinkel J, Francois S, Gorin NC, Chapel A.

Immunol Res. 2013 Jul;56(2-3):241-8. doi: 10.1007/s12026-013-8397-8. Review.

PMID:
23564182
5.

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, van den Brink GR, Hommes DW.

Gut. 2010 Dec;59(12):1662-9. doi: 10.1136/gut.2010.215152. Epub 2010 Oct 4.

PMID:
20921206
6.

Treatment of inflammatory diseases with mesenchymal stem cells.

Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A.

Inflamm Allergy Drug Targets. 2009 Jun;8(2):110-23. Review.

PMID:
19530993
7.

Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.

Leal A, Ichim TE, Marleau AM, Lara F, Kaushal S, Riordan NH.

Cell Immunol. 2008 May-Jun;253(1-2):11-5. doi: 10.1016/j.cellimm.2008.06.003. Epub 2008 Jul 15. Review.

PMID:
18627903
8.

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.

Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR.

Gut. 2011 Jun;60(6):788-98. doi: 10.1136/gut.2010.214841. Epub 2011 Jan 21.

PMID:
21257987
9.

Role of mesenchymal stem cell therapy in Crohn's disease.

Dalal J, Gandy K, Domen J.

Pediatr Res. 2012 Apr;71(4 Pt 2):445-51. doi: 10.1038/pr.2011.56. Epub 2012 Feb 8. Review.

PMID:
22430380
10.

Immunosuppressive properties of mesenchymal stem cells: advances and applications.

De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F.

Curr Mol Med. 2012 Jun;12(5):574-91. Review.

PMID:
22515979
11.

Remestemcel-L, the first cellular therapy product for the treatment of graft-versus-host disease.

Daly A.

Drugs Today (Barc). 2012 Dec;48(12):773-83. doi: 10.1358/dot.2012.48.12.1885866. Review.

PMID:
23243634
12.

The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation.

Kim EJ, Kim N, Cho SG.

Exp Mol Med. 2013 Jan 10;45:e2. doi: 10.1038/emm.2013.2. Review.

13.

Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?

Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, Ritter T.

Stem Cells. 2013 Oct;31(10):2033-41. doi: 10.1002/stem.1452. Review.

14.

Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.

Amorin B, Alegretti AP, Valim V, Pezzi A, Laureano AM, da Silva MA, Wieck A, Silla L.

Hum Cell. 2014 Oct;27(4):137-50. doi: 10.1007/s13577-014-0095-x. Epub 2014 Jun 6. Review.

15.

Potential therapeutic applications of mesenchymal stromal cells.

Larsen S, Lewis ID.

Pathology. 2011 Oct;43(6):592-604. doi: 10.1097/PAT.0b013e32834ab72d.

PMID:
21876470
16.

Mesenchymal stromal cell therapy for Crohn's disease.

Liew A, O'Brien T, Egan L.

Dig Dis. 2014;32 Suppl 1:50-60. doi: 10.1159/000367826. Epub 2014 Dec 17. Review.

PMID:
25531353
17.

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.

Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R, Kurtzberg J.

Biol Blood Marrow Transplant. 2011 Apr;17(4):534-41. doi: 10.1016/j.bbmt.2010.04.014. Epub 2010 May 8.

18.

Overview of stem cell therapy for Crohn's disease.

Dryden GW.

Expert Opin Biol Ther. 2009 Jul;9(7):841-7. doi: 10.1517/14712590902956615. Review.

PMID:
19527107
20.

Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: a canine model of human fistulizing Crohn's disease.

Ferrer L, Kimbrel EA, Lam A, Falk EB, Zewe C, Juopperi T, Lanza R, Hoffman A.

Regen Med. 2016 Jan;11(1):33-43. doi: 10.2217/rme.15.69. Epub 2015 Sep 21.

Supplemental Content

Support Center